Filing Details

Accession Number:
0001181431-13-052152
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-02 19:25:29
Reporting Period:
2013-09-30
Filing Date:
2013-10-02
Accepted Time:
2013-10-02 19:25:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
861838 Idera Pharmaceuticals Inc. IDRA Biological Products, (No Disgnostic Substances) (2836) 043072298
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193366 El Youssef Zein Pillar Invest Offshore Sal, Starko Ctr,
Bloc B, 3Rd Floor, Omar Daouk Street
Beirut M8 2020-3313
Yes No Yes No
1534428 Pillar Invest Corp C/O Idera Pharmaceuticals, Inc.
167 Sidney Street
Cambridge MA 02139
Yes No Yes No
1588130 Pillar Pharmaceuticals Iv, L.p. Pillar Invest Offshore Sal Starco Ctr
Bloc B, 3Rd Floor, Omar Daouk Street
Beirut M8 2020-3313
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-30 845,161 $0.00 0 No 4 P Indirect See Footnotes
Common Stock Acquisiton 2013-09-30 929,032 $0.00 0 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnotes
No 4 P Indirect See Footnotes
Footnotes
  1. On September 30, 2013, upon the consummation of a public offering of the Issuer (the "Offering"), Pillar Pharmaceuticals IV, L.P. ("Pillar IV"), of which Pillar GP is the general partner, acquired, in the Offering, 845,161 shares of common stock (the "Pillar IV Shares") of the Issuer. Pillar GP disclaims Section 16 beneficial ownership of the Pillar IV Shares and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar IV. As of the date hereof, Pillar IV owns directly 845,161 shares of common stock of the Issuer.
  2. On September 30, 2013, upon the consummation the Offering, Participations Besancon ("Besancon"), a fund advised by Pillar GP, acquired, in the Offering, 929,032 shares of common stock (the "Besancon Shares"). Pillar GP also disclaims Section 16 beneficial ownership of the Besancon Shares and this report shall not be deemed an admission that Pillar GP is the beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, resulting from fees payable to Pillar GP in its capacity as investment advisor to Besancon. As of the date hereof, Besancon owns directly 3,329,032 shares of common stock of the Issuer.
  3. Youssef El Zein is a director and controlling stockholder of Pillar GP and serves as the representative of Pillar IV and Pillar GP on the Issuer's board of directors. Mr. El Zein disclaims Section 16 beneficial ownership of the Pillar IV Shares and the Besancon Shares and this report shall not be deemed an admission that he is the beneficial owners of any such securities, except to the extent of his pecuniary interest therein, if any, by virtue of his ownership interest in Pillar GP. As of the date hereof, Mr. El Zein owns directly 586,101 shares of common stock of the Issuer.